SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-19-000853
Filing Date
2019-05-15
Accepted
2019-05-15 09:01:13
Documents
50
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inmb_10q.htm 10-Q 276479
2 CERTIFICATION inmb_ex311.htm EX-31.1 7136
3 CERTIFICATION inmb_ex312.htm EX-31.2 7391
4 CERTIFICATION inmb_ex321.htm EX-32.1 3150
5 CERTIFICATION inmb_ex322.htm EX-32.2 3101
12 inmb_10qimg1.jpg GRAPHIC 72891
13 inmb_10qimg2.jpg GRAPHIC 97095
14 inmb_10qimg3.jpg GRAPHIC 86521
  Complete submission text file 0001640334-19-000853.txt   2633865

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inmb-20190331.xml EX-101.INS 320540
7 XBRL TAXONOMY EXTENSION SCHEMA inmb-20190331.xsd EX-101.SCH 34313
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inmb-20190331_cal.xml EX-101.CAL 20541
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inmb-20190331_def.xml EX-101.DEF 124981
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inmb-20190331_lab.xml EX-101.LAB 285095
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inmb-20190331_pre.xml EX-101.PRE 212289
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 19825301
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1